HU1000284D0 - Use of f1 alpha and it's derivatives of prostaglandin for reducing inflammation - Google Patents

Use of f1 alpha and it's derivatives of prostaglandin for reducing inflammation

Info

Publication number
HU1000284D0
HU1000284D0 HU1000284A HUP1000284A HU1000284D0 HU 1000284 D0 HU1000284 D0 HU 1000284D0 HU 1000284 A HU1000284 A HU 1000284A HU P1000284 A HUP1000284 A HU P1000284A HU 1000284 D0 HU1000284 D0 HU 1000284D0
Authority
HU
Hungary
Prior art keywords
prostaglandin
alpha
derivatives
reducing inflammation
inflammation
Prior art date
Application number
HU1000284A
Other languages
Hungarian (hu)
Original Assignee
Avidin Kft
Ubichem Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidin Kft, Ubichem Kft filed Critical Avidin Kft
Priority to HU1000284A priority Critical patent/HUP1000284A3/en
Publication of HU1000284D0 publication Critical patent/HU1000284D0/en
Priority to PCT/HU2011/000050 priority patent/WO2011154754A1/en
Publication of HUP1000284A2 publication Critical patent/HUP1000284A2/en
Publication of HUP1000284A3 publication Critical patent/HUP1000284A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU1000284A 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation HUP1000284A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1000284A HUP1000284A3 (en) 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation
PCT/HU2011/000050 WO2011154754A1 (en) 2010-06-01 2011-06-01 USE OF PROSTAGLANDIN F1α AND ITS DERIVATIVES FOR REDUCTION OF INFLAMMATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1000284A HUP1000284A3 (en) 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation

Publications (3)

Publication Number Publication Date
HU1000284D0 true HU1000284D0 (en) 2010-07-28
HUP1000284A2 HUP1000284A2 (en) 2012-03-28
HUP1000284A3 HUP1000284A3 (en) 2012-08-28

Family

ID=89989751

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1000284A HUP1000284A3 (en) 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation

Country Status (2)

Country Link
HU (1) HUP1000284A3 (en)
WO (1) WO2011154754A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954741A (en) * 1972-06-07 1976-05-04 Pfizer Inc. N-substituted prostaglandin carboxamides
US4085139A (en) * 1975-12-29 1978-04-18 The Upjohn Company 2-Decarboxy-2-amino-methyl-PGE and PGD analogs
AU2003228819A1 (en) * 2002-05-03 2003-11-17 Combinatorx, Incorporated Combinations for the treatment of inflammatory skin disorders
CA2647859C (en) * 2006-03-29 2016-01-05 Nitromed, Inc. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use

Also Published As

Publication number Publication date
HUP1000284A2 (en) 2012-03-28
HUP1000284A3 (en) 2012-08-28
WO2011154754A1 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
EP2611413A4 (en) Skin compositions and methods of use thereof
EP2536283A4 (en) Phenyl-heteroaryl derivatives and methods of use thereof
EP2536756A4 (en) Hsa-related compositions and methods of use
EP2685882A4 (en) Tissue retractor and methods of use
EP2584897A4 (en) Resveratrol-containing compositions and methods of use
SG10202009963PA (en) Melanin modification compositions and methods of use
PL2448581T3 (en) Therapeutic compositions and related methods of use
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
IL236830A0 (en) Diazahomoadamantane derivatives and methods of use thereof
EP2596112A4 (en) Acetycysteine compositions and methods of use thereof
EP2654745A4 (en) Composition for the treatment of skin conditions
EP2419399A4 (en) Compositions and methods for the treatment of inflammation
EP2619194A4 (en) Fatty acid derivatives of catechins and methods of their use
IL225793A0 (en) Methods and compositions for the treatment of insulin-associated medical conditions
ZA201402758B (en) Brimonidine gel compositions and methods of use
IL223514A0 (en) Benzamide derivatives and their use as hsp90 inhibitors
EP2601930A4 (en) Agent for enhancing whitening effect and use of same
PL2616062T3 (en) Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents
EP2635293A4 (en) Skin wound healing compositions and methods of use thereof
ZA201208775B (en) Gel formulations for the topical use of 1-amino-alkycyclohexane derivatives
PL2609156T3 (en) Drag reducing compositions and methods of manufacture and use
WO2011130552A9 (en) Serca2 therapeutic compositions and methods of use
HK1214771A1 (en) Formulations for use in the treatment of skin conditions
HU1000284D0 (en) Use of f1 alpha and it's derivatives of prostaglandin for reducing inflammation

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees